MedscapeCME Cardiology Podcast
Summary: Medscape offers free CME activities for physicians and other health professionals. Medscape is organized by medical specialty, with each supported specialty having its own customized Web site. Specialty content is evaluated, created, and presented under the guidance of a Medscape program director and a medical professional advisory board.
- Visit Website
- RSS
- Artist: MedscapeCME
- Copyright: Copyright 2014, Medscape
Podcasts:
Examine strategies to streamline care in the emergency department, resulting in improved survival and enduring quality of life.
Drs. Smith and Batchelor review possible reasons for poorer outcomes in black patients undergoing stent implantation.
Join Drs. Felker, Piña, and Januzzi as they discuss the use of cardiac biomarkers to gauge therapeutic success in different age groups.
Darren McGuire, MD, explores the relationship between type 2 diabetes and diabetes therapies on CV risk in this interactive program.
Join Drs. Davidson, Toth, and Boden as they discuss the results of the AIM-HIGH trial and its implications on the treatment of low HDL-C with currently available agents.
Repercussions from the surprising results from PALLAS. Drs. Camm, Connolly, and Le Heuzey discuss implications for patient care.
Join Drs. Eckel, Ridker, and Cannon for a panel discussion on the relationship among LDL-C, low HDL-C, and therapies in development targeting residual CV risk.
Updated guidelines on use of antiplatelet agents in ACS. Drs. Bates, James, Montelescot, and Storey discuss the winners and losers.
Aspirin increases bleeding; rates are higher with dual therapy. But stopping antiplatelets increases cardiovascular events. Drs. Mehran and Scheiman discuss how to strike the right balance.
Achieve optimal outcomes in the patient with CKD by managing mineral and bone disturbances through a consistent team strategy.
Join Drs. Fuster, Barter, and Toth as they discuss the challenges of identifying statin intolerance in elderly patients and how to manage it effectively.
Do therapies that promote nitric oxide release improve endothelial dysfunction? Drs. Weber, Mason, Cockcroft, and Fonseca review the latest data.
Hitting the sweet spot for antiplatelet efficacy. Is platelet reactivity the answer? Drs. Lopes and Becker explore the possibilities.
Join our experts, Drs. McLaughlin, McGoon, and Tapson, as they discuss improved medical developments for treating patients with PAH.
Personalization of medical care using a biomarker approach. The future is almost here. Drs. Piña, Januzzi, Felker, and O'Connor discuss biomarkers old and new in the management of heart failure.
